Amyotrophic Lateral Sclerosis (ALS)

Study of COYA 302 for the Treatment of ALS

Personalized Antisense Oligonucleotide Therapy for Participants With TARDBP ALS

Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis

Safety Study of XT-150 in Participants With ALS

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III

Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Serum Neurofilaments in the Diagnosis of Amyotrophic Lateral Sclerosis

HD-tDCS in Amyotrophic Lateral Sclerosis: A Multicenter Randomized Controlled Trial

HEALEY ALS Platform Trial - Regimen I NUZ-001

Personalized Antisense Oligonucleotide Therapy for a Participant With TARDBP ALS

Intestinal Microbiome Transplant in ALS

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)